NCT00016861View on ClinicalTrials.gov

Irinotecan in Treating Children With Refractory or Progressive Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Study Completion Date

January 31, 2005

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

irinotecan hydrochloride

Trial Locations (1)

77030-2399

Texas Children's Cancer Center, Houston

All Listed Sponsors
lead

Texas Children's Cancer Center

OTHER

NCT00016861 - Irinotecan in Treating Children With Refractory or Progressive Solid Tumors | Biotech Hunter | Biotech Hunter